Financhill
Back

Integra Lifesciences Holdings 10K Form

Sell
44

IART
Integra Lifesciences Holdings

Last Price:
24.14
Seasonality Move:
8.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive IART News And Ratings

See the #1 stock for the next 7 days that we like better than IART

IART Financial Statistics

Sales & Book Value

Annual Sales: $1.54B
Cash Flow: $10.69M
Price / Cash Flow: 32.03
Annual Sales: $19.77
Price / Book: 1.22

Profitability

EPS (TTM): 0.29000
Net Income (TTM): $23.65M
Gross Margin: $884.74M
Return on Equity: 1.48%
Return on Assets: 0.61%

Integra Lifesciences Holdings Earnings Forecast

Key Integra Lifesciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 29 years for IART is 57.39%.
  • The Selling, General & Administrative Expenses for IART have been equal to 42.60% of Gross Profit Margin.
  • The Research & Development expenses have been 6.76% of Revenue.
  • The Interest Expense is 75.84% of Operating Income.
  • The Net Earning history of IART is 4.39% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Integra Lifesciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: IART
CUSIP: 457985
Website: integralife.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 3.39
Quick Ratio: 1.73

Price-to-Earnings

Trailing P/E Ratio: 28.7
Forward P/E Ratio: 9.64

IART Technical Analysis vs Fundamental Analysis

Sell
44
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy or a Sell?